🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

DJ Lakkireddy Andrea Russo Vivek Y. Reddy Arwa Younis MD Mina Chung MD Jag Singh Pugal Vijayaraman Varun Sundaram, MD, PhD, MSc, FRCP (UK) Jodie Hurwitz John Triedman MD Valentina Kutyifa Shunmuga Sundaram Ponnusamy Girish M. Nair Sana Al-Khatib Andrea Natale MD @FredSacher_EP Kenneth Ellenbogen Jose Luis Merino Roderick Tung

📌 Planning your #HRS2025 schedule? Pace Setter Alexandra M. Sanchez, MD (@alysanchezmd) shares her top 3 sessions to watch: bit.ly/3EbIPZl #2025PaceSetter

Immediately following the #LBCT presentation at #HRS2025, Heart Rhythm TV host Nashwa Abdulsalam sat down with Varun Sundaram, MD, PhD, MSc, FRCP (UK) to discuss TRANSFORM-AF:Targeting Metabolic Therapy with GLP-1 Receptor Agonism for Secondary Prevention in Atrial Fibrillation. See the full interview here

NEW #HRS2025 SCIENCE: The #TRANSFORMAF study found that patients with #AFib and obesity treated with GLP-1 receptor agonists experienced fewer AF-related events. Key Takeaways: 1️⃣ 2,510 patients across 170 VA hospitals nationwide 2️⃣ GLP-1 RA use led to 13% reduction in major

Dr Rosalynn Austin RN European Society of Cardiology HFAPresident Shelley Zieroth Harriette Van Spall, MD MPH 🇨🇦 Amina Giuseppe Galati Muthu Vaduganathan Cornelia Margineanu Novi Yanti Sari Johann Bauersachs Alejandro Recio Maggie Simpson Marat Fudim, MD MHS Andreas Gevaert Dr. Purvi Parwani Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 SABOURETCardiologist Henry Han Hany Ragy European Society of Cardiology Journals Prof. Izabella Uchmanowicz, RN, PhD,MBA,FESC, FHFA So many interesting trials, for me PREFERHH too🙂 Also PRAISE-HFrEF (GLP-1 in trend), REDICAE trial and trial with digoxin

Hottest trials and trial updates is starting at Room1🔥 📍FINEARHF Blinded drug withdrawal Muthu Vaduganathan 📍FAIR-HF2 DZHK05 #StefanAnker 📍FUTURE-HF Kevin Damman 📍SOGALDI-PEF #JoaoFerreira 📍PRAISE-HFrEF #VarunSundaram 📍HELIOS-B: Vutrisiran reduces all-cause mortality

Full house at the first Late-Breaking ‘Hottest Trials & Trial Updates’ session! 🔥 Standing room only for the latest in cutting-edge #HeartFailure research Congratulations for all of the investigators and amazing discussions #HeartFailure2025

Passionate discussion of the importance of GLP-1 in heart failure patients with obesity by Mark Petrie, when discussing the PRAISE-HFrEF trial #HeartFailure2025

🔥HOT #HeartFailure2025 PRAISE-HFrEF 📍No suggestion of⬆️ HFH or ☠️ with GLP1-RA use at diabetes doses 📍Probable safety of GLP-1RA in clinically severe HFrEF with obesity 📍Hypothesis generating data 📍Need for RCT at weight loss doses, especially with severe obesity and/or CKD

🎙️NEW #HeartFailure2025 #LBCT Interview 💫Dr Varun Sundaram, MD, PhD, MSc, FRCP (UK) discusses findings from the PRAISE-HFrEF study. 📽️Watch here👉 ow.ly/9f2b50VUwOc #CVRM #HFrEF #GLP1 #CardioEd #ESC_HFA

ESC HF 25: The PRAISE-HFrEF Study | Radcliffe Cardiovascular-Renal-Metabolic radcliffecvrm.com/video-index/es…

Is GLP-1RA use harmful or safe in patients with HFrEF and obesity? Varun Sundaram, MD, PhD, MSc, FRCP (UK) shares the results of the PRAISE-HFrEF study. Watch: pace-cme.org/congress-cover… #HeartFailure2025 #HFrEF #Obesity #PRAISEHFrEF #GLP1RA